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Abstract
Background: Body fat is related to changes in lipid profile, blood pressure and metabolism of insulin and glucose, 
known as the metabolic syndrome (MS). The aim of this study was to estimate the prevalence of metabolic syndrome 
(MS) and its components among overweight and obese Portuguese schoolchildren, and to identify associated clinical 
and biochemical characteristics.
Methods: A total of 82 children (14 overweight and 68 obese; 40 boys and 42 girls) aged 7-9 years, underwent 
anthropometric measurements. A blood sample was obtained to assess biochemical parameters. Insulin resistance (IR) 
was determined by the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). MS was defined by the 
National Cholesterol Education Program Adult Treatment Panel III criteria modified by Cook.
Results: The prevalence of MS was 15.8%. Abdominal obesity was present in all children. Frequency of elevated blood 
pressure, low HDL-cholesterol and elevated triglyceride concentrations were 62.6%, 13.4% and 11.0%, respectively. 
None of the children presented impaired fasting glucose, however hyperinsulinemia (7.3%) and IR (8.5%) were 
observed. The number of components of MS was higher in children with higher z-BMI (ρ = 0.411; p < 0.001). MS was 
associated with higher leptin concentrations. No association was found with adiponectin or ghrelin levels. Leptin 
correlated positively with obesity, glucose metabolism, lipid profile, hepatic function and C-reactive protein, and 
negatively with HDL and Apolipoprotein A-I/B ratio.
Conclusions: This study shows a significant prevalence of MS among obese schoolchildren. Abdominal obesity and 
elevated blood pressure were the most frequent components of this syndrome. Dyslipidemia, IR and high levels of 
leptin were also associated with MS in this young group.
Background
In the past decades the prevalence of childhood obesity
has increased worldwide, reaching epidemic proportions
and becoming a serious and growing public health prob-
lem [1,2]. In Portugal, in a nationwide study, the preva-
lence of excess weight in 7-9 year-old children was 31.5%
[3]. This is similar to what we found in a previous local
study of 920 children from Aveiro (28%) [4].
The coexistence of obesity and metabolic disorders
such as hyperinsulinemia, glucose intolerance, hyperten-
sion, high serum levels of triglycerides (TG) and
decreased levels of high density lipoprotein (HDL), is
known as metabolic syndrome (MS) [5]. This constella-
tion of symptoms, first described by Reaven [6], increases
the risk for cardiovascular disease (CVD) and type 2 dia-
betes (DM2) [7]. Insulin resistance (IR) and an altered
plasma lipid pattern are common pathophysiological fea-
tures of MS, not only in adults but also in children and
adolescents [7]. However, there is no consensus about the
definition of MS in paediatric populations [8]. Many dif-
ferent MS criteria have been employed in children and
adolescents, and the components and cut-offs used to
diagnose this syndrome have varied considerably among
studies [8-10]. Recently, a new consensus definition has
been published, however according to it, in children
younger than 10 years-old MS should not be diagnosed
[11]. Changes in growth and development during child-
hood and adolescence make it difficult to choose a cut-off
for risk factors [12]. Therefore, the prevalence varies
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according to the definitions used [8]. It has been reported
to be relatively low in normal weight children (1% or less)
contrary to what occurs in obese (18% to 50%) [13].
Moreover, MS is rapidly increasing in prevalence with ris-
ing childhood obesity and sedentary lifestyles worldwide
[13]. In addition, parameters associated with MS have
been shown to originate early in life [9], and tend to track
into adulthood [14]. The recognition of MS in obese chil-
dren, who have not yet developed cardiometabolic disor-
ders, is of great importance from a clinical and public
health perspective [15].
The MS has been widely studied in adults, however
there is little research focusing on younger children (< 10
y old) [16]. Moreover, the absence of studies on MS in the
p a e d i a t r i c  P o r t u g u e s e  p o p u l a t i o n  l e d  u s  t o  d e s i g n  t h e
current study. The aims of this study were to determine
the prevalence of MS and its individual components in a
sample of Portuguese obese schoolchildren, and to iden-
tify clinical or biochemical characteristics associated with
MS in our population.
Methods
Study Population
Recruitment of the study sample was population-based
[4]. In brief, from a total of forty schools with 1799
schoolchildren enrolled at 2nd  and 3rd  grade (aged
between 7-9 years), a random sample of 13 schools was
selected and a representative sample of 980 children was
obtained. Weight, height and waist circumference were
evaluated in 905 children (457 boys and 448 girls). Of
those, 127 (14%) were classified as obese (≥ 95th BMI per-
centile) according to the US Centers for Disease Control
and Prevention (CDC) criteria [17], and were invited to
participate in the study. Eighty-nine accepted the invita-
tion and 82 (64.5% of the initial sample; 40 boys and 42
girls) allowed collection of blood.
Each parent gave written informed consent and chil-
dren gave assent for participation. The study was
approved by the Ethics Committee of the Hospital Infante
D. Pedro. Assessments were carried out at the Depart-
ment of Endocrinology, Diabetes and Nutrition.
None of the evaluated children suffered from primary
dyslipidemia, hypertension, diabetes or glucose intoler-
ance, secondary obesity, or were under pharmacological
treatment.
Anthropometric Measures
Weight, height and waist circumference were measured
according to standardized procedures [18]. All measure-
ments were taken in underwear and without shoes.
Weight was measured to the nearest 0.1 kg using a elec-
tronic column scale (SECA-780; Seca Ltd., Hamburg,
Germany); height was measured to the nearest 0.1 cm
using a stadiometer (SECA-220; Seca Ltd.), with the head
in the Frankfort horizontal plane; waist circumference
(WC) was measured with a non-elastic, flexible tape
measured at the mid-point between the iliac crest and the
lower edge of the ribs at the end of a normal expiration.
Age was calculated in decimal units based on the date of
the survey relative to birth date. BMI was calculated with
measured height and weight and was standardised (z-
BMI) by using age- and gender-normative data from the
CDC [17,19]. Abdominal obesity was defined using the
sex and age-specific 90th waist circumference percentile
by McCarthy et al [20]. Birth weight and length were
obtained from the children health booklet.
Clinical and Biochemical Measures
A physical examination was performed looking for char-
acteristic abnormalities, specifically acanthosis nigricans.
Puberty status was assessed according to pubic hair in
boys and pubic hair and breast development in girls
[21,22]. Blood pressure (BP) was obtained on the right
arm with the patient seated, after rest, using a digital
sphygmomanometer (OMRON M6) and appropriate
sized cuff. After three measurements, the lowest blood
pressure value was chosen. Children were classified
according to sex, height and age-specific charts [23].
Baseline blood samples were collected in the morning
(8:00 to 9:00) after an overnight fast (10 to 12 hours) by
venipuncture, after a local application of a topical anes-
thetic patch (EMLA). Plasma and serum were separated
by centrifugation. The glucose oxidase method (Siemens
Healthcare Diagnostics Inc., Newark, DE, USA) was used
to determine blood glucose levels. Serum lipids (total
cholesterol (T-chol), HDL, LDL, triglycerides) were mea-
sured using an enzymatic colorimetric method (Siemens
Healthcare Diagnostics Inc.). Very low density lipopro-
tein (VLDL) was calculated using the principles of the
Friedewald formula, and the Apolipoprotein A-I and
Apolipoprotein B were measured by an immuno-turbidi-
metric assay (Olympus America Inc., Center Valley, PA,
USA). Plasma liver enzyme (alanine aminotransferase
(ALT), aspartate aminotransferase (AST), gama-glutam-
yltransferase (GGT)) levels were measured using an enzy-
matic colorimetric method (Siemens Healthcare
Diagnostics Inc.), and C-reactive protein (CRP) was
determined by a turbidimetric immunoassay (Siemens
Healthcare Diagnostics Inc.). Plasma and serum were fro-
zen until further analysis of insulin, C-peptide, leptin,
adiponectin and ghrelin at an external laboratory
(ENDOCLAB, Porto). Insulin and C-peptide were mea-
sured by luminescence immunometric assay (Siemens
Healthcare Diagnostics Inc.). Insulin resistance was
determined by the Homeostasis Model Assessment of
Insulin Resistance (HOMA-IR) calculated as the product
of the fasting plasma insulin level (μUI/ml) and the fast-
ing plasma glucose level (mmol/l), divided by 22.5 [24].Pedrosa et al. Diabetology & Metabolic Syndrome 2010, 2:40
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Leptin, adiponectin and ghrelin were quantified by RIA
(Linco Research Inc., St. Charles, MO, USA).
Definition of MS
MS was defined according to the National Cholesterol
Education Program Adult Treatment Panel III criteria
modified by Cook [10], with adjustment for fasting glu-
cose according to the recent American Diabetes Associa-
tion definition for impaired fasting glucose [25]. This
definition was chosen since it is based in age- and gender-
specific cutoffs and it has been used in several paediatric
studies [8,26]. Thus, MS was considered if three or more
of the following criteria were present: 1) abdominal obe-
sity (WC ≥ 90th percentile for age and sex) [20]; 2) fasting
TG ≥ 110 mg/dl; 3) HDL ≤ 40 mg/dl; 4) systolic/diastolic
BP ≥ 90th percentile for age, sex and height [23]; 5) fasting
glucose ≥ 100 mg/dl [25].
Statistical Analysis
Descriptive statistics were executed by computing the
mean and standard deviation (SD) for scale variables, or
frequencies for nominal variables. Pearson and Spearman
c o r r e l a t i o n  c oe f f i c i e n t s  w e r e  c o m p u t e d  t o  eva l u a t e  t h e
degree of association between variables. To study the
independence between nominal categorical variables
Chi-square test was used. Independent samples t test was
performed in scale variables to evaluate the differences
between two groups. Mann-Whitney test was used in
ordinal variables to evaluate the differences between two
groups. The normality of scale variables was assessed
using the Kolmogorov-Smirnov test. Non parametric
tests were applied to variables with a distribution signifi-
cantly different from the Normal. We considered a signif-
icance level of 0.05. Statistical analysis was performed
using the Statistical Package for the Social Sciences (SPSS
version 14.0, 2005).
Results
The anthropometric and clinical characteristics of the 82
children (48.8% boys and 51.2% girls) are shown in Table
1. A statistical significant difference between genders was
found for height, z-IMC, WC and the presence of acan-
thosis, with boys presenting higher values. Mean plas-
matic concentration of total cholesterol (169.4 ± 27.1 mg/
dl), HDL (50.1 ± 9.7 mg/dl), LDL (106.9 ± 23.2 mg/dl), TG
(77.7 ± 47.3 mg/dl), insulin (8.6 ± 4.2 μUI/ml), glucose
(82.0 ± 6.7 mg/dl), AST (25.3 ± 4.9 U/L), ALT (20.3 ± 8.0
U/L) and GGT (15.6 ± 6.4 U/L) were within normal range
for both genders. Plasma liver enzymes showed signifi-
cant higher concentrations in boys: ALT (26.5 ± 5.5 vs
24.1 ± 4.0 U/L; p = 0.021), AST (22.8 ± 9.7 vs 17.8 ± 5.0 U/
L; p = 0.005) and GGT (17.1 ± 8.1 vs 14.2 ± 3.6 U/L; p =
0.043). About three quarters of the sample were prepu-
bertal (Tanner I: 74.4%; Tanner II: 25.6%). The prevalence
of MS in our children was 15.8%, without significant dif-
ferences between boys and girls. None of the children ful-
filled the five criteria of the MS.
Between the assessment at school and the first assess-
ment at the Hospital, 14 (17.1%) children who were classi-
f i e d  i n i t i a l l y  a s  o b e s e  ( ≥  9 5 th BMI percentile) became
overweight (85-95th BMI percentile). In addition to the
significantly higher values in anthropometric parameters,
the levels of systolic BP (117.2 ± 9.1 vs. 111.9 ± 7.4
mmHg; p = 0.047) and C-peptide (1.0 ± 0.5 vs. 0.8 ± 0.3
ng/ml; p = 0.010) were also found significantly higher in
obese children. Glucose, insulin and HOMA-IR showed a
trend towards higher levels in obese subjects, as well as
blood lipids (except HDL), leptin and GGT, without sta-
tistical significance (data not shown). None of the over-
weight children had 3 or more diagnostic criteria for MS
or presented acanthosis. In obese, 13 (19.1%) presented
MS and 18 (26.5%) presented acanthosis.
As shown in Table 2, BMI, z-BMI, WC, systolic BP and
the presence of acanthosis were significantly higher in
MS children than in non-MS sufferers. The number of
components of MS was higher in children with higher z-
BMI (ρ = 0.411, p < 0.001). We found significant differ-
ences between the presence and the absence of MS for
several biochemical characteristics (Table 3). The num-
ber of criteria for MS correlated with several characteris-
tics of the population, however most of these correlations
were weak (|ρ| < 0.5), except for systolic BP (ρ = 0.682, p <
0.001).
All children presented abdominal obesity (WC ≥ 90th),
while high BP (≥ 90th) was the second most frequent com-
ponent of MS (62.6%) (Figure 1). Frequency of high TG
and low HDL was 13.4% and 11.0%, respectively. Abnor-
mal fasting glucose values were not identified in any of
the children, however IR occurred in 8.5% (23.1% in MS-
children vs. 5.8% non-MS), hyperinsulinemia (plasma
insulin >15 μUI/ml) in 7.3% and acanthosis was present
in 22.0%.
Leptin correlated positively (p < 0.05) with BMI, z-BMI,
WC, insulin, HOMA-IR, C-peptide, T-chol, LDL, TG,
Apolipoprotein B, ALT, GGT and CRP, and negatively
with HDL and Apolipoprotein A-I/B, but most correla-
tions were weak (|R|,|ρ|<0.5). Adiponectin showed a neg-
ative (p < 0.05) but weak (|R|, |ρ|<0.5) correlation with
diastolic BP and birth weight, without any significant cor-
relation with obesity. Also a negative (p < 0.05) and weak
(|R|, |ρ|<0.5) correlation was found between ghrelin and
age, weight, BMI, systolic BP, insulin and HOMA-IR.
Discussion
Our study presents the first Portuguese report on the fre-
q u e n cy  o f  M S  a n d  a s s o c i a t e d  m e t a b o l i c  c o m p l i c a t i o n s
among overweight and obese children aged 7-9 years.
Since our study was population-based, not hospital-Pedrosa et al. Diabetology & Metabolic Syndrome 2010, 2:40
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based, the severity of obesity was moderate (z-BMI mean:
1.93 ± 0.28). We found a high prevalence of MS (19.1%) in
obese children, while it was absent in the overweight.
Nevertheless, all children presented abdominal obesity, a
criterion of MS. The observed prevalence of MS in our
study is similar to data from other European countries
[8,15,26]. However, when considering the definition
applied, large differences are noticed [8,15]. Thus, a con-
sensual paediatric definition of MS is needed in order to
better compare studies and populations. Boys and puber-
tal subjects usually present higher frequencies of MS
[9,10], however we did not found a significant difference
in the prevalence of MS according to gender or pubertal
status.
Childhood obesity is frequently associated with cardio-
vascular and metabolic disturbances [13]. In the present
study, several biochemical parameters failed to present a
significant difference between overweight and obese chil-
Table 1: Descriptive characteristics of the population study, according to gender.
Boys (n = 40) Girls (n = 42) p
Age (y) 8.7 ± 0.8 8.6 ± 0.7 0.721a
Weight (kg) 43.5 ± 6.4 41.4 ± 6.0 0.128a
Height (cm) 136.8 ± 5.9 134.2 ± 5.6 0.049a
BMI (kg/m2) 23.14 ± 2.22 22.85 ± 2.07 0.530a
z-BMI 2.00 ± 0.29 1.86 ± 0.26 0.026a
Waist circumference (cm) 74.1 ± 5.8 71.5 ± 5.9 0.044a
Systolic BP (mmHg) 117.2 ± 8.1 115.4 ± 9.8 0.402a
Diastolic BP (mmHg) 64.0 ± 10.9 61.9 ± 8.3 0.330a
HOMA-IR 1.71 ± 0.90 1.79 ± 0.89 0.798b
Birth weight (g) 3523 ± 429 3337 ± 472 0.072a
Acanthosis (n; %) 13 (32.5%) 5 (11.9%) 0.024c
Metabolic Syndrome (n; %) 6 (15.0%) 7 (16.7%) 0.836c
Data presented as mean ± SD for continuous variables and as frequency (%) for dichotomous variables.
a t-student test for the differences between genders.
b Mann-Whitney for the differences between genders.
c Chi-square test for the independence between gender and each variable.
Table 2: Descriptive characteristics of the population study according to the presence or absence of MS.
Without MS (n = 69) With MS (n = 13) P
Age (y) 8.7 ± 0.7 8.4 ± 0.8 0.167a
Weight (kg) 41.9 ± 6.3 45.1 ± 5.2 0.091a
Height (cm) 135.4 ± 5.9 136.2 ± 5.5 0.635a
BMI (kg/m2) 22.75 ± 2.13 24.23 ± 1.74 0.021a
z-BMI 1.89 ± 0.26 2.15 ± 0.25 0.002a
Waist circumference (cm) 72.1 ± 5.9 76.4 ± 5.0 0.016a
Systolic BP (mmHg) 114.9 ± 8.3 123.5 ± 9.2 0.001a
Diastolic BP (mmHg) 62.7 ± 10.2 63.9 ± 6.7 0.675a
Birth weight (g) 3443 ± 442 3328 ± 546 0.412a
Gender (M/F) 34/35 6/7 0.836b
Tanner (I/II) 49/20 12/1 0.107b
Acanthosis (n; %) 11 (15.9%) 7 (53.8%) 0.002b
Data presented as mean ± SD for continuous variables and as frequency for dichotomous variables.
a t-student test for the differences between absence or presence of MS.
b Chi-square test for the independence between absence or presence of MS and each variable.Pedrosa et al. Diabetology & Metabolic Syndrome 2010, 2:40
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dren, except for systolic BP and C-peptide levels that
were significantly higher in obese. This lack of difference
may be due to the moderate grade of obesity and lower
SD of z-BMI of our sample. We observed that children
with MS presented higher z-BMI and largest significant
differences in clinical and biochemical characteristics
compared to those without MS. The reason why some
obese children developed this syndrome, while others do
not is still unknown [16]. This may be due to the presence
of other underlying factors, such as IR. Indeed, IR seems
to be an important pathophysiologic event contributing
to MS, becoming more important than overall adiposity
in the development of this syndrome [5,27]. In fact, in our
study IR was lower in the obese relatively to MS-children.
This alerts to the possibility that obese children with 2 or
m o r e  M S  c o m p o n e n t s  m i g h t  f o r m  a  h i g h  r i s k  g r o u p
within the obese population.
All evaluated children presented abdominal obesity,
which is related with increased metabolic risk factors for
DM2 and CVD [28]. Elevated BP was the second most
common feature of MS, reaching about 2/3 of our sample,
which is a remarkably high frequency. In obese children
from several European countries, a lower frequency
(38%) was reported [15], similar to a study with US chil-
dren (7-9 years-old) [16]. The differences found may be
do to different methodology, since we used a digital
sphygmomanometer which may overestimate blood pres-
sure levels. It also may be due to distinct dietary habits in
our population, namely sodium intake. Systolic BP was
significantly (ρ = 0.682; p < 0.001) correlated to the num-
ber of factors of MS.
Dyslipidemia is less prevalent, however the lipid profile
can be considered more 'atherogenic' in MS children,
with higher TG, LDL, VLDL and apolipoprotein B, and
lower HDL and apolipoprotein A-I. Indeed, it is well
established that atherosclerosis begins in childhood and
is associated with several risk factors for MS [26].
Although the younger age of our sample, the children
with MS already presented acanthosis, elevated insulin
and C-peptide levels and increased HOMA-IR. Despite
this, fasting glucose levels were normal which reflects the
range of abnormalities of glucose homeostasis associated
with childhood obesity. In fact, even in the obese, high
fasting glycemia is not common in the paediatric age [29].
Table 3: Biochemical characteristics of the population study according to the presence or absence of MS.
Without MS (n = 69) With MS (n = 13) p
Glucose (mg/dl) 81.8 ± 6.6 82.9 ± 7.4 0.580a
Insulin (μUI/ml) 8.1 ± 3.6 11.3 ± 6.3 0.037b
C-Peptide (ng/ml) 0.9 ± 0.5 1.2 ± 0.5 0.044b
HOMA-IR 1.64 ± 0.77 2.31 ± 1.25 0.028b
T-chol (mg/dl) 167.6 ± 25.5 179.2 ± 33.9 0.156a
HDL (mg/dl) 51.9 ± 8.9 40.4 ± 8.4 < 0.001a
LDL (mg/dl) 104.5 ± 21.5 119.7 ± 28.3 0.030a
Triglycerides (mg/dl) 63.4 ± 19.2 153.7 ± 74.7 < 0.001b
VLDL (mg/dl) 12.7 ± 3.8 30.7 ± 14.9 < 0.001b
T-chol/HDL 3.27 ± 0.50 4.54 ± 0.98 < 0.001b
Apolipoprotein A-I (mg/dl) 126.2 ± 14.9 114.1 ± 14.7 0.008a
Apolipoprotein B (mg/dl) 75.4 ± 13.8 87.7 ± 18.2 0.006a
Apolipoprotein A-I/B 1.73 ± 0.37 1.36 ± 0.37 0.001a
C-reactive protein (mg/dl) 0.38 ± 0.81 0.31 ± 0.23 0.283b
Leptin (ng/ml) 10.6 ± 5.8 15.5 ± 7.8 0.011a
Adiponectin (ng/ml) 26428.1 ± 12915.0 26136.9 ± 11291.1 0.940a
Ghrelin (pg/ml) 1051.1 ± 420.3 985.1 ± 380.7 0.600a
AST (U/L) 25.0 ± 6.3 26.8 ± 6.3 0.437b
ALT (U/L) 19.4 ± 7.2 25.2 ± 10.3 0.011b
GGT (U/L) 14.7 ± 4.1 20.6 ± 12.0 0.008b
Data presented as mean ± SD.
a t-student test for the differences between absence or presence of MS.
b Mann-Whitney for the differences between absence or presence of MS.Pedrosa et al. Diabetology & Metabolic Syndrome 2010, 2:40
http://www.dmsjournal.com/content/2/1/40
Page 6 of 7
This suggests that impaired glucose levels or pre-diabetes
develops later than the other MS components, while IR is
the earlier and predominant abnormality of glucose
metabolism found in obesity [30]. Indeed, excess weight
in children and adolescents may serve to accelerate the
onset of DM2 in childhood [5].
Higher levels of hepatic enzymes (ALT, AST and GGT)
were found in boys and in children with MS and obesity,
although within normal range values. This gender-differ-
ence may be due to a larger liver mass in males [31]. Non-
alcoholic fatty liver disease is considered the hepatic
manifestation of the MS in adults [32]. Currently, this
condition is related with child obesity and considered a
major cause of abnormal liver function tests in paediatric
populations [31,32].
In our sample, leptin levels were correlated to obesity,
glucose metabolism, an 'atherogenic' lipid profile and to
liver function. Consequently, the presence of MS was
associated with significant higher levels of this adipose-
tissue hormone. Leptin is described to be positively cor-
related with both BMI and fasting insulin levels [33].
Chronic insulin increase favours an increase in leptin,
which in turn would perpetuate the increase in insulin
and favour the onset of IR. This leptin-insulin association
begins before puberty and may be connected to the onset
of MS [33].
Bacha et al [34] reported that adiponectin is inversely
associated with obesity and is an important determinant
of insulin sensivity and HDL in children. However, we did
not verify these relations. This is possibly due to the small
sample size and more homogeneous characteristics of
our sample, without severe obese children. In this study,
adiponectin levels showed a weak and negative correla-
tion with diastolic BP and birth weight.
Ghrelin, an orexigenic peptide secreted by the stomach,
is documented to be inversely correlated to obesity, insu-
lin and IR indexes in children [35,36], such as confirmed
in our study. The negative relationship between fasting
ghrelin concentration and obesity might be explained by
an inhibitory effect of insulin on ghrelin, since a higher IR
is associated with visceral fat accumulation [35].
Conclusions
Our results showed a significant prevalence of MS and its
cardiometabolic complications in Portuguese obese
schoolchildren. Abdominal obesity was present in all
c h i l d r e n  a n d  t h e  f r e q u e n c y  o f  e l e v a t e d  B P  l e v e l s  w a s
markedly high. None of the children presented impaired
fasting glucose. The fact that the clustering of metabolic
risk factors in childhood predicts the development of MS
into adulthood highlights the importance of better
understanding the longer-term health implications of this
syndrome in children. Also, a consensual definition of
paediatric MS is needed for proper screening, evaluation
and treatment of children at risk or with MS. The imple-
mentation of preventive measures is urgently required
since lifestyle modifications and weight loss may lead to
favourable changes in risk factors.
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Figure 1 Frequency of the components of MS in total children, 
children without MS and children with MS. MS: Metabolic syn-
drome; NMS-c: children without MS (n = 69); MS-c: children with MS (n 
= 13); WC: waist circumference; TG: triglycerides; HDL: HDL-cholesterol; 
BP: blood pressure; FG: fasting glucose.
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